GUTS
Fractyl HealthยทNASDAQ
--
--(--)
--
--(--)
GUTS Profile
Fractyl Health, Inc.
A diabetes and obesity therapy research and development company
Life Science Tools and Services
08/30/2010
02/02/2024
NASDAQ Stock Exchange
100
12-31
Common stock
3 Van de Graaff Drive, Suite 200, Burlington, MA 01803
--
Fractyl Health, Inc., was incorporated in Delaware on August 30, 2010. The company is a clinical-stage metabolic therapy company focused on developing new approaches to treat obesity and type 2 diabetes. Its lead product candidate, the Revita DMR System, is designed to reshape the duodenal mucosa to address the underlying cause of metabolic disease.
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
